Location: Chicago, IL
CIK: 0000314957 · Show all filings
Period: Q4 2024 (← Previous) (Next →)
Filing Date: Feb 5, 2025
Total Value: $107M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BND | VANGUARD BD INDEX FDS TOTAL BND MRKT | 552,830 | $39.75M | 37.3% | — | — | TOTAL BND MRKT | 921937835 |
| VT | VANGUARD INTL EQUITY INDEX F | 285,449 | $33.53M | 31.5% | — | — | TT WRLD ST ETF | 922042742 |
| VOO | VANGUARD INDEX FDS | 60,891 | $32.81M | 30.8% | — | — | S&P 500 ETF SHS | 922908363 |
| NKGN | NKGEN BIOTECH INC | 550,000 | $360K | 0.3% | — | — | COM | 65488A101 |
| PYXS | PYXIS ONCOLOGY INC | 48,731 | $76,020 | 0.1% | — | — | COMMON STOCK | 747324101 |